title: Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
abstract: Using AR4-2J rat pancreatic carcinoma cells, the effects of a novel bombesin (BN) receptor antagonist [D-F5Phe6, D-Ala11]BN(6-13)OMe (BIM26226) on BN- or GRP-stimulated amylase release and binding of radio-labeled bombesin-like peptides to these cells were examined and compared to [D-Phe6,Leu13 psi(CH2NH)Leu14]BN(6-14) (Psi Bn(6-14)), one of the most potent BN receptor antagonists presently known. BN and GRP both stimulated amylase release with EC50 values in the nanomolar range. Both antagonists were devoid of agonist activity when tested alone. BIM26226 was most potent, antagonizing BN- or GRP-stimulated amylase release with IC50 values in the nanomolar range, whereas Psi Bn(6-14) was approximately ten times less potent. With 125I-[Tyr15]GRP bound to these cells, the binding affinities were BIM26226 > GRP > Psi Bn(6-14) >> neuromedin B. BIM 22626 was not able to inhibit binding of radio-labeled CCK-33, gastrin-17 or VIP. These results suggest that BIM26226 is one of the most potent and specific bombesin receptor antagonists in vitro and seems to be a useful tool to define the physiologic role of GRP in vivo.
authors.affiliation: Department of Research, University Hospital, Basel, Switzerland.
authors.forename: J B
authors.initials: JB
authors.lastname: Dietrich
authors.forename: P
authors.initials: P
authors.lastname: Hildebrand
authors.forename: L B
authors.initials: LB
authors.lastname: Jeker
authors.forename: A
authors.initials: A
authors.lastname: Pansky
authors.forename: A N
authors.initials: AN
authors.lastname: Eberle
authors.forename: C
authors.initials: C
authors.lastname: Beglinger
mesh_terms: D000681:Amylases / Q000378:metabolism*; D000818:Animals; D001667:Binding, Competitive; D001839:Bombesin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D019886:Gastrin-Releasing Peptide; D005755:Gastrins / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D010190:Pancreatic Neoplasms; D010446:Peptide Fragments / Q000494:pharmacology*; D010455:Peptides / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D018004:Receptors, Bombesin / Q000037:antagonists & inhibitors*; D014407:Tumor Cells, Cultured
chemical_list: C091872:BIM 26226; D005755:Gastrins; D010446:Peptide Fragments; D010455:Peptides; D018004:Receptors, Bombesin; C091873:bombesin (6-14), Phe(6)-Leu(13)-psi(CH2NH)-Leu(14)-; D019886:Gastrin-Releasing Peptide; D000681:Amylases; D001839:Bombesin